Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Aceragen, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 47 | 34 | −13 |
| Shares | 6.21M | 4.25M | −1.95M (−31.5%) |
| Value | $6.39M | $2.42M | −$3.97M (−62.1%) |
New holders (3)
Institutions that held Aceragen, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 48,568 | $28.0K | 0.00% |
| Two Sigma Securities, LLC | 17,781 | $10.0K | 0.00% |
| Engineers Gate Manager LP | 15,333 | $9.00K | 0.00% |
Sold out (16)
Institutions that held Aceragen, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace, LLP | 407,227 | $419.0K |
| Renaissance Technologies LLC | 271,640 | $280.0K |
| Two Sigma Investments, LP | 265,850 | $274.0K |
| DCM Advisors, LLC | 105,007 | $108.0K |
| Palo Alto Investors LP | 77,044 | $79.0K |
| Price T Rowe Associates Inc | 60,400 | $62.0K |
| Goldman Sachs Group Inc | 39,326 | $41.0K |
| ExodusPoint Capital Management, LP | 25,835 | $27.0K |
| Manufacturers Life Insurance Company, The | 13,933 | $14.0K |
| Assenagon Asset Management S.A. | 13,488 | $14.0K |
| People's United Financial, Inc. | 11,501 | $12.0K |
| Simplex Trading, LLC | 9,822 | $11.0K |
| Meeder Asset Management Inc | 833 | $1.00K |
| FMR LLC | 471 | $0 |
| Harbour Investments, Inc. | 7 | $0 |
| Meridian Wealth Partners, LLC | 45 | $0 |